HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Systemic Haemophilus influenzae infections in a community hospital: prevalence of ampicillin resistance.

Abstract
Ampicillin-resistant strains are presently known to account for 10% to 20% of type b Haemophilus influenzae infections in the United States. To determine whether the incidence in a community hospital parallels that of several university hospitals, we reviewed medical records of the 99 children with type b Haemophilus systemic infections for the period 1976 to 1979. These cass represented 1.8% of all pediatric medical admissions. In 1976-1977, 5% of those infections were caused by resistant strains; the incidence increased to 19% for the period 1978-1979. This increase on a community hospital level parallels the increase in ampicillin resistance in Haemophilus noted in university hospitals and underscores the need for chloramphenicol (alone or in combination with ampicillin) as initial treatment for systemic Haemophilus infections.
AuthorsR H Schwartz, R I Goldenberg, C Park, E V Soto
JournalSouthern medical journal (South Med J) Vol. 74 Issue 2 Pg. 151-2, 156 (Feb 1981) ISSN: 0038-4348 [Print] United States
PMID6970415 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Chloramphenicol
  • Ampicillin
Topics
  • Ampicillin (therapeutic use)
  • Child
  • Chloramphenicol (therapeutic use)
  • Haemophilus Infections (drug therapy, epidemiology)
  • Haemophilus influenzae (drug effects)
  • Hospitals, Community
  • Hospitals, University
  • Humans
  • Penicillin Resistance

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: